Why Chemotherapy That Costs $70,000 in the U.S. Costs $2,500 in IndiaThomas BollykyThe Atlantic Apr. 14, 2013 |
Mike Johnson Pushes Debunked Lie That Israeli Babies Were 'Cooked in Ovens' On October 7
'Sniper Seen on Roof Overlooking Pro-Palestine Protest' at Indiana University
'It Has to Be Stopped': Netanyahu Demands Pro-Palestine Protests at U.S. Colleges Be Shut Down
Claim Jewish Student Was 'Stabbed In The Eye' by Pro-Palestine Protester Draws Mockery After Video Released
'These Protesters Belong in Jail': Gov. Abbott Cheers Arrest of Pro-Palestine Protesters at UT Austin
Why does Gleevec, a leukemia drug that costs $70,000 per year in the United States, cost just $2,500 in India? It's seemingly simple. Gleevec is under patent in the U.S., but not in India. Accordingly, Novartis, its Swiss-based manufacturer, may prevent competitors from making and selling lower-cost versions of the drug in the U.S., but not in India. Read More |